Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Identifying the Optimal Conditioning Intensity of Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in Complete Remission

Blood (2023) 142 (Supplement 1): 2150.

https://doi.org/10.1182/blood-2023-181621

Published: 2023

Journal Articles

Prognostic Impact of Chromosomal Abnormalities in TP53 -Mutated Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes

Blood (2023) 142 (Supplement 1): 4328.

https://doi.org/10.1182/blood-2023-180291

Published: 2023

Journal Articles

CR1 Favors PTCy-haplo over UCB in Allogeneic Stem Cell Transplantation for Adult Patients with AL

Tomoyasu Jo, Tomoaki Ueda, Yu Akahoshi, Tadakazu Kondo, Naoyuki Uchida, Masatsugu Tanaka, Hirohisa Nakamae, Noriko Doki, Shuichi Ota, Masashi Sawa, Hiroyuki Ohigashi, Yumiko Maruyama, Nobuyuki Takayama, Tetsuya Nishida, Yoshinobu Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Yasuyuki Arai

Blood (2023) 142 (Supplement 1): 2175.

https://doi.org/10.1182/blood-2023-182588

Published: 2023

Journal Articles

iPLAT1: the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study

Blood (2022) 140 (22): 2398–2402.

https://doi.org/10.1182/blood.2022017296

Published: 2022

Includes: Supplemental data

Journal Articles

Booster Dose of mRNA-Based COVID-19 Vaccine Induces a Humoral and Cellular Response in Patients Recently Treated with Anti-CD20 Monoclonal Antibodies

Masashi Nishikubo, Yoshimitsu Shimomura, Ryusuke Yamamoto, Hayato Maruoka, Seiko Nasu, Tomomi Nishioka, Kenji Sakizono, Satoshi Mitsuyuki, Tomoyo Kubo, Naoki Okada, Daishi Nakagawa, Kimimori Kamijo, Hiroharu Imoto, Yuya Nagai, Nobuhiro Hiramoto, Satoshi Yoshioka, Noboru Yonetani, Tadakazu Kondo, Takayuki Ishikawa

Blood (2022) 140 (Supplement 1): 2633–2634.

https://doi.org/10.1182/blood-2022-162172

Published: 2022

Journal Articles

Risk Stratification of Diffuse Large B-Cell Lymphoma Based on Cell Surface Markers Using Flow Cytometry

Tomoyo Kubo, Yoshimitsu Shimomura, Hayato Maruoka, Yuya Nagai, Tadakazu Kondo, Takayuki Ishikawa

Blood (2022) 140 (Supplement 1): 3842–3843.

https://doi.org/10.1182/blood-2022-162248

Published: 2022

Journal Articles

The Duration of Coronavirus Disease 2019 (COVID-19) Clearance in Patients with Hematological Malignancies Can be Stratified By the Number of Chemotherapy Treatment and Severity of COVID-19

Masashi Nishikubo, Yoshimitsu Shimomura, Yuya Nagai, Tadakazu Kondo, Takayuki Ishikawa

Blood (2022) 140 (Supplement 1): 11195–11196.

https://doi.org/10.1182/blood-2022-166433

Published: 2022

Journal Articles

Comparing Single Cord Blood Transplantation and Matched Related Donor Transplantation in Non-Remission Acute Myeloid Leukemia

Blood (2021) 138 (Supplement 1): 1790.

https://doi.org/10.1182/blood-2021-147645

Published: 2021

Journal Articles

Single Cord Blood Transplantation Versus HLA-Haploidentical Related Donor Transplantation Using Post-Transplant Cyclophosphamide in Patients with Hematological Malignancies

Blood (2021) 138 (Supplement 1): 2927.

https://doi.org/10.1182/blood-2021-149403

Published: 2021

Journal Articles

The First-in-Human Clinical Trial of iPSC-Derived Platelets (iPLAT1): Autologous Transfusion to an Aplastic Anemia Patient with Alloimmune Platelet Transfusion Refractoriness

Naoshi Sugimoto, Junya Kanda, Sou Nakamura, Toshiyuki Kitano, Masakatsu Hishizawa, Tadakazu Kondo, Shin Shimizu, Akiko Shigemasa, Hideyo Hirai, Harue Tada, Manabu Minami, Naohide Watanabe, Masayuki Nogawa, Makoto Handa, Yoshihiko Tani, Akifumi Takaori-Kondo, Koji Eto

Blood (2021) 138 (Supplement 1): 351.

https://doi.org/10.1182/blood-2021-145814

Published: 2021

Journal Articles

The Impact of Anti-Microbial Drug-Drug Interactions on Acute Kidney Injury after Allogeneic Hematopoietic Cell Transplantation

Fumiya Wada, Yasuyuki Arai, MDPhD, Junya Kanda, MD PhD, Toshio Kitawaki, MD PhD, Masakatsu Hishizawa, MD PhD, Tadakazu Kondo, MD PhD, Kouhei Yamashita, MD PhD, Akifumi Kondo Takaori, MD PhD

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-139100

Published: 2020

Journal Articles

Risk Factors and the Therapeutic Efficacy for Thrombotic Microangiopathy in Patients after Allogeneic Hematopoietic Stem Cell Transplantation - Results of the Multicenter Retrospective Cohort Study

Hiroharu Imoto, Hiroyuki Matsui, MD, Yasuyuki Arai, MD PhD, Tadakazu Kondo, MD PhD, Yasunori Ueda, MD PhD, Kazunori Imada, MD PhD, Takashi Akasaka, MD PhD, Akihito Yonezawa, MD PhD, Kazuhiro Yago, MD PhD, Takayuki Ishikawa, MD PhD, Akifumi Takaori-Kondo, MD PhD

Blood (2019) 134 (Supplement_1): 4554.

https://doi.org/10.1182/blood-2019-123252

Published: 2019

Journal Articles

Impact of HLA Class I Allele Mismatch on Viral Infection within 100 Days after Cord Blood Transplantation

Tomoki Iemura, MD, Yasuyuki Arai, MD PhD, Junya Kanda, MD, Toshio Kitawaki, MD PhD, Masakatsu Hishizawa, MD PhD, Tadakazu Kondo, MD PhD, Kouhei Yamashita, MD PhD, Akifumi Takaori-Kondo, MD PhD

Blood (2019) 134 (Supplement_1): 3267.

https://doi.org/10.1182/blood-2019-123073

Published: 2019

Journal Articles

Establishment of a Predictive Model of GvHD-Free, Relapse-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation Using a Machine Learning Algorithm

Blood (2019) 134 (Supplement_1): 3337.

https://doi.org/10.1182/blood-2019-123241

Published: 2019

Journal Articles

Risk Factors and Predictive Scoring System for Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation

Ayumi Fujimoto, MD, Nobuhiro Hiramoto, MD, Satoshi Yamasaki, MD PhD, Yoshihiro Inamoto, MD PhD, Naoyuki Uchida, MD PhD, Tetsuo Maeda, MD, Takehiko Mori, MD PhD, Yoshinobu Kanda, MD PhD, Tadakazu Kondo, MD PhD, Junji Tanaka, MD PhD, Tatsuo Ichinohe, MD PhD, Yoshiko Atsuta, MD PhD, Masao Ogata, MD PhD, Ritsuro Suzuki, MD PhD

Blood (2018) 132 (Supplement 1): 250.

https://doi.org/10.1182/blood-2018-99-110424

Published: 2018

Journal Articles

Clinical Analysis of Immunodeficiency-Associated Lymphoproliferative Disorders in a Single Institution

Mizuki Watanabe, MD, Junya Kanda, MD, Yasuyuki Arai, MD PhD, Momoko Nishikori, MD PhD, Masakatsu Hishizawa, MD PhD, Tadakazu Kondo, MD PhD, Kouhei Yamashita, MD PhD, Akifumi Kondo Takaori, MD PhD

Blood (2018) 132 (Supplement 1): 5398.

https://doi.org/10.1182/blood-2018-99-115532

Published: 2018

Journal Articles

Prediction of Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation Using a Machine Learning Algorithm

Yasuyuki Arai, MDPhD, Tadakazu Kondo, MD PhD, Kyoko Fuse, MD, Yasuhiko Shibasaki, MD, Masayoshi Masuko, MD PhD, Junichi Sugita, Takanori Teshima, Naoyuki Uchida, MD PhD, Takahiro Fukuda, Kazuteru Ohashi, MD PhD, Yukiyasu Ozawa, MD PhD, Tatsuo Ichinohe, MD PhD, Yoshinobu Kanda, MD PhD, Yoshiko Atsuta, MD PhD

Blood (2018) 132 (Supplement 1): 68.

https://doi.org/10.1182/blood-2018-99-114794

Published: 2018

Journal Articles

The Impact of the Use and Type of Antibiotics on Acute-Versus-Host Disease

Katsuyuki Nishi, MD, Junya Kanda, MD PhD, Masakatsu Hishizawa, MD PhD, Toshiyuki Kitano, MD, Tadakazu Kondo, MD PhD, Kouhei Yamashita, MD PhD, Akifumi Takaori-Kondo, MD PhD

Blood (2017) 130 (Supplement 1): 4508.

https://doi.org/10.1182/blood.V130.Suppl_1.4508.4508

Published: 2017

Journal Articles

Patient-Reported Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Types and Severity of Chronic Gvhd

Saiko Kurosawa, MD, Kumi Oshima, Takuhiro Yamaguchi, Atsumi Yanagisawa, Takahiro Fukuda, Heiwa Kanamori, MD, Takehiko Mori, MD PhD, Satoshi Takahashi, MD PhD, Tadakazu Kondo, MD PhD, Akio Kohno, Aika Seto, MD, Yukari Umemoto, Takanori Teshima, MD PhD, Shuichi Taniguchi, MD PhD, Takuya Yamashita, Yoshiko Atsuta, MD PhD

Blood (2016) 128 (22): 1240.

https://doi.org/10.1182/blood.V128.22.1240.1240

Published: 2016

Journal Articles

Clinical Outcomes of Patients with Primary Myelofibrosis in Japan: A Nationwide Survey over a 17-Year Study Period

Katsuto Takenaka, MD PhD, Kazuya Shimoda, MD, PhD, Naoyuki Uchida, MDPhD, Taizo Shimomura, MD PhD, Koji Nagafuji, MD PhD, Tadakazu Kondo, MD PhD, Hirohiko Shibayama, MDPhD, Takehiko Mori, MD PhD, Kensuke Usuki, MD PhD, Taichi Azuma, MDPhD, Yutaka Tsutsumi, MD PhD, Junji Tanaka, MD PhD, Hitomi Dairaku, Keitaro Matsuo, MDPhD, Keiya Ozawa, MD PhD, Mineo Kurokawa, MD, PhD, Shunya Arai, MD, PhD, Koichi Akashi, MD PhD

Blood (2016) 128 (22): 3126.

https://doi.org/10.1182/blood.V128.22.3126.3126

Published: 2016

NARROW

Identifying the Optimal Conditioning Intensity of Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in Complete Remission

Prognostic Impact of Chromosomal Abnormalities in TP53 -Mutated Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes

CR1 Favors PTCy-haplo over UCB in Allogeneic Stem Cell Transplantation for Adult Patients with AL

iPLAT1: the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study

Booster Dose of mRNA-Based COVID-19 Vaccine Induces a Humoral and Cellular Response in Patients Recently Treated with Anti-CD20 Monoclonal Antibodies

Risk Stratification of Diffuse Large B-Cell Lymphoma Based on Cell Surface Markers Using Flow Cytometry

The Duration of Coronavirus Disease 2019 (COVID-19) Clearance in Patients with Hematological Malignancies Can be Stratified By the Number of Chemotherapy Treatment and Severity of COVID-19

Comparing Single Cord Blood Transplantation and Matched Related Donor Transplantation in Non-Remission Acute Myeloid Leukemia

Single Cord Blood Transplantation Versus HLA-Haploidentical Related Donor Transplantation Using Post-Transplant Cyclophosphamide in Patients with Hematological Malignancies

The First-in-Human Clinical Trial of iPSC-Derived Platelets (iPLAT1): Autologous Transfusion to an Aplastic Anemia Patient with Alloimmune Platelet Transfusion Refractoriness

The Impact of Anti-Microbial Drug-Drug Interactions on Acute Kidney Injury after Allogeneic Hematopoietic Cell Transplantation

Risk Factors and the Therapeutic Efficacy for Thrombotic Microangiopathy in Patients after Allogeneic Hematopoietic Stem Cell Transplantation - Results of the Multicenter Retrospective Cohort Study

Impact of HLA Class I Allele Mismatch on Viral Infection within 100 Days after Cord Blood Transplantation

Establishment of a Predictive Model of GvHD-Free, Relapse-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation Using a Machine Learning Algorithm

Risk Factors and Predictive Scoring System for Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation

Clinical Analysis of Immunodeficiency-Associated Lymphoproliferative Disorders in a Single Institution

Prediction of Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation Using a Machine Learning Algorithm

The Impact of the Use and Type of Antibiotics on Acute-Versus-Host Disease

Patient-Reported Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Types and Severity of Chronic Gvhd

Clinical Outcomes of Patients with Primary Myelofibrosis in Japan: A Nationwide Survey over a 17-Year Study Period

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only